Key result
Accompanying dyspnea in suspected ACS is linked to ~2.5-fold higher 2-year mortality.
Why the study?
The presence of accompanying dyspnea is common in chest pain patients with suspected ACS, but its impact on differential diagnoses, diagnostic work-up, and outcome is incompletely understood.
Does the presence of accompanying dyspnea affect differential diagnoses, diagnostic work-up performance, and two-year all-cause mortality in patients presenting to the emergency department with chest pain suggestive of acute coronary syndromes?
Cohort (n=6,045)
Yes
Does the presence of accompanying dyspnea affect differential diagnoses, diagnostic work-up performance, and two-year all-cause mortality in patients presenting to the emergency department with chest pain suggestive of acute coronary syndromes?
In patients presenting with chest pain and suspected ACS, accompanying dyspnea does not increase the likelihood of ACS or impair the accuracy of hs-cTn and ESC 0/1h diagnostic algorithms, but it identifies patients with higher rates of non-coronary cardiac disease and independently predicts two-year all-cause mortality.
Answers are grounded in this paper and cite their sources.
Dyspnea flags higher mortality during MI evaluation; leaves open whether it refines ESC 0/1h algorithms.
Background The presence of accompanying dyspnea is routinely assessed and common in chest pain patients with suspected acute coronary syndromes (ACS), but its impact on differential diagnoses, diagnostic work-up and outcome is incompletely understood. Purpose To determine the association of accompanying dyspnea with diagnoses, diagnostic work-up, and outcome of patients presenting with suspected ACS to the emergency department (ED). Methods We prospectively enrolled unselected patients presenting to the ED with chest pain as the main symptom suggestive of ACS in an international multicenter study. Final diagnoses were adjudicated by two independent cardiologists using all information including cardiac imaging. Patients were stratified by the presence or absence of self-reported dyspnea. The primary diagnostic endpoint was the differential diagnosis. The secondary diagnostic endpoint was the performance of high-sensitivity cardiac troponin (hs-cTn) and the European Society of Cardiology (ESC) 0/1h-algorithms for the diagnosis of myocardial infarction (MI). The primary prognostic endpoint was all-cause mortality at two years. Results Among 6045 patients, 2892/6045 (48%) had accompanying dyspnea. Final diagnoses in patients with versus without dyspnea were different (overall p<0.001), but prevalence of ACS was comparable (MI 22.4% vs. 21.9%, p=0.602, unstable angina 8.7% vs. 7.9%, p=0.291). In contrast, patients with dyspnea more often had cardiac, non-coronary disease (15.3% vs. 10.2%, p<0.001). Diagnostic accuracy of high-sensitivity cardiac troponin (hs-cTn)T/I concentrations at presentation for the diagnosis of MI was high and not affected by the presence of dyspnea (area under the curve 0.89–0.91 in both groups). The ESC 0/1h-algorithms performed excellent in both groups with negative predictive values >99.4%. The presence of dyspnea was associated with all-cause death at two years (hazard ratio [HR] 2.487 [95% CI, 2.001–3.091, p<0.001) and remained an independent predictor after adjustment for covariates at baseline (HR 1.813 [95% CI, 1.453–2.261, p=0.001]). Overall mortality rates were higher in patients with dyspnea at two years (9.0% vs. 3.7%, p<0.001). Conclusion Accompanying dyspnea was not associated with a higher prevalence of ACS but with cardiac, non-coronary disease such as heart failure. While the safety of the diagnostic work-up was not affected, accompanying dyspnea was associated with and an independent predictor for two-year all-cause mortality. Funding Acknowledgement Type of funding sources: Other. Main funding source(s): Swiss Heart Foundation, University of Basel.
No takes yet. Share an insight, caveat, or question.
Boeddinghaus et al. (2022) conducted a cohort in Suspected acute coronary syndromes (n=6,045). Accompanying self-reported dyspnea vs. Absence of self-reported dyspnea was evaluated on All-cause mortality at two years (primary prognostic endpoint); differential diagnosis (primary diagnostic endpoint) (HR 2.487, 95% CI 2.001-3.091, p=<0.001). Accompanying dyspnea in suspected ACS patients was associated with higher 2-year all-cause mortality, without increasing ACS prevalence.
Synapse has enriched 10 related papers. Consider them for comparative context: